Portfolio (Quarterly)
Guide ↗
Knott David M Jr
· CIK 0001892770| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PTGX | Protagonist Therapeutics, Inc | Healthcare | 63,000.0 | $6.6M | 3.95% | -10K | -13.7% | $105.40 | -5.9% |
| 2 | TVTX | Travere Therapeutics, Inc. | Healthcare | 140,633.0 | $4.2M | 2.49% | -45K | -24.4% | $29.71 | +49.5% |
| 3 | CPRX | Catalyst Pharmaceuticals, Inc. | Healthcare | 120,000.0 | $3.0M | 1.77% | -69K | -36.5% | $24.76 | +26.3% |
| 4 | ACLX | Arcellx Inc | Healthcare | 19,433.0 | $2.2M | 1.33% | -6K | -24.4% | $114.82 | +0.2% |
| 5 | RCUS | Arcus Biosciences, Inc. | Healthcare | 81,241.0 | $1.8M | 1.04% | -40K | -33.0% | $21.60 | +8.5% |
| 6 | CYTK | Cytokinetics, Incorporated | Healthcare | 23,644.0 | $1.6M | 0.93% | -10K | -30.5% | $65.91 | +16.7% |
| 7 | JNJ | Johnson & Johnson | Healthcare | 4,922.0 | $1.2M | 0.72% | -2K | -28.9% | $244.44 | -4.1% |
| 8 | BMY | Bristol-Myers Squibb Company | Healthcare | 13,622.0 | $826K | 0.49% | -8K | -38.1% | $60.65 | -2.0% |
| 9 | BIIB | Biogen Inc. | Healthcare | 4,000.0 | $733K | 0.44% | -2K | -33.3% | $183.33 | +5.7% |
| 10 | — | Solid Bioscience Inc. | — | 47,143.0 | $339K | 0.20% | -115K | -71.0% | $7.20 | — |
| 11 | LENZ | LENZ Therapeutics, Inc. | Healthcare | 33,732.0 | $309K | 0.18% | -20K | -37.2% | $9.15 | -17.5% |
| 12 | WVE | Wave Life Science Ltd. | Healthcare | 40,000.0 | $290K | 0.17% | -50K | -55.6% | $7.25 | -12.0% |
| 13 | — | Jasper Therapeutics, Inc. | — | 160,789.0 | $141K | 0.08% | -21K | -11.4% | $0.88 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
58.3%
Financial Services
21.5%
Communication Services
17.3%
Technology
1.5%
Energy
0.6%
Consumer Defensive
0.3%
Basic Materials
0.2%
Real Estate
0.2%
Consumer Cyclical
0.1%
Industrials
0.1%